SAPROPTERIN DIHYDROCHLORIDE
Generic: SAPROPTERIN DIHYDROCHLORIDE
Aurobindo Pharma LimitedManufacturer
ORALRoute
SAPROPTERIN DIHYDROCHLORIDEActive Substance
2025-06-09Original Approval
SAPROPTERIN DIHYDROCHLORIDE is FDA application ANDA216797, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
PRODUCT DOSE OMISSION ISSUE
41 reports
2
HEADACHE
24 reports
3
DIARRHOEA
22 reports
4
AMINO ACID LEVEL INCREASED
20 reports
5
DRUG INEFFECTIVE
20 reports
6
EXPOSURE DURING PREGNANCY
19 reports
7
VOMITING
18 reports
8
ABDOMINAL DISCOMFORT
16 reports
9
DECREASED APPETITE
16 reports
10
OVERDOSE
16 reports